205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-2.31%
Revenue decline while MCHP shows 9.52% growth. Joel Greenblatt would examine competitive position erosion.
-4.95%
Cost reduction while MCHP shows 9.67% growth. Joel Greenblatt would examine competitive advantage.
2.08%
Gross profit growth below 50% of MCHP's 9.36%. Michael Burry would check for structural issues.
4.49%
Margin expansion while MCHP shows decline. John Neff would investigate competitive advantages.
-1.79%
R&D reduction while MCHP shows 10.21% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-7.56%
Operating expenses reduction while MCHP shows 6.83% growth. Joel Greenblatt would examine advantage.
-5.72%
Total costs reduction while MCHP shows 8.68% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
60.24%
D&A growth above 1.5x MCHP's 0.64%. Michael Burry would check for excessive investment.
59.31%
EBITDA growth exceeding 1.5x MCHP's 8.20%. David Dodd would verify competitive advantages.
63.07%
EBITDA margin growth while MCHP declines. John Neff would investigate advantages.
24.74%
Operating income growth exceeding 1.5x MCHP's 12.28%. David Dodd would verify competitive advantages.
27.68%
Operating margin growth exceeding 1.5x MCHP's 2.52%. David Dodd would verify competitive advantages.
-82.46%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
6.98%
Pre-tax income growth 50-75% of MCHP's 12.40%. Martin Whitman would scrutinize operations.
9.50%
Pre-tax margin growth exceeding 1.5x MCHP's 2.64%. David Dodd would verify competitive advantages.
7.50%
Tax expense growth 50-75% of MCHP's 12.38%. Bruce Berkowitz would examine efficiency.
587.55%
Net income growth exceeding 1.5x MCHP's 12.41%. David Dodd would verify competitive advantages.
603.78%
Net margin growth exceeding 1.5x MCHP's 2.64%. David Dodd would verify competitive advantages.
558.82%
EPS growth exceeding 1.5x MCHP's 8.99%. David Dodd would verify competitive advantages.
568.75%
Diluted EPS growth exceeding 1.5x MCHP's 8.99%. David Dodd would verify competitive advantages.
0.89%
Share count reduction below 50% of MCHP's 1.45%. Michael Burry would check for concerns.
0.76%
Diluted share reduction below 50% of MCHP's 1.45%. Michael Burry would check for concerns.